Defining phenotypes and cancer risk in hyperplastic polyposis syndrome

Diseases of the Colon and Rectum

Volumn 54, Issue 2, 2011, Pages 164-170

  Kalady, Matthew F ^a   Jarrar, Awad ^a   Leach, Brandie ^a   La Guardia, Lisa ^a   O'Malley, Margaret ^a   Eng, Charis ^a   Church, James M ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Colon cancer; Hyperplastic polyposis; Hyperplastic polyps; Serrated polyps

Indexed keywords

ADULT; AGED; CANCER RISK; COLON POLYP; COLONOSCOPY; COLORECTAL CANCER; CONFERENCE PAPER; FAMILY HISTORY; FEMALE; HUMAN; HYPERPLASTIC POLYPOSIS SYNDROME; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; RELATIVE; SIGMOID;

ADENOMA; ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTESTINAL POLYPOSIS; MALE; MIDDLE AGED; NEOPLASMS; PHENOTYPE; PRECANCEROUS CONDITIONS;

EID: 78651398693     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1007/DCR.0b013e3181fd4c15     Document Type: Conference Paper

References (24)

1. Chan TL, Zhao W, Leung SY, Yuen ST, Cancer Genome Project. BRAF and KRAS mutations in colorectal hyperplastic polyps and serrated adenomas. Cancer Res. 2003;63:4878-4881.
2. East JE, Saunders BP, Jass JR. Sporadic and syndromic hyperplastic polyps and serrated adenomas of the colon: classification, molecular genetics, natural history, and clinical management. Gastroenterol Clin N Am. 2008;37:25-46.
3. Jass JR. Serrated route to colorectal cancer: back street or super highway? J Pathol. 2001;193:283-285.
4. Chow E, Lipton L, Lynch E, et al. Hyperplastic polyposis syndrome: phenotypic presentations and the role of MBD4 and MYH. Gastroenterology. 2006;131:30-39.
5. Ferrández A, Samowitz W, DiSario JA, Burt RW. Phenotypic characteristics and risk of cancer development in hyperplastic polyposis: case series and literature review. Am J Gastroenterol. 2004;99:2012-2018.
6. Hyman NH, Anderson P, Blasyk H. Hyperplastic polyposis and the risk of colorectal cancer. Dis Colon Rectum. 2004;47:2101-2114.
7. Leggett BA, Devereaux B, Biden K, Searle J, Young J, Jass J. Hyperplastic polyposis: association with colorectal cancer. Am J Surg Pathol. 2001;25:177-184.
8. Rubio CA, Stemme S, Jaramillo E, Jaramillo E. Hyperplastic polyposis coli syndrome and colorectal carcinoma. Endoscopy. 2006;38:266-270.
9. Yeoman A, Young J, Arnold J, Jass J, Parry S. Hyperplastic polyposis in the New Zealand population: a condition associated with increased colorectal cancer risk and European ancestry. N Z Med J. 2007;120: U2827.
10. Burt, R, Jass, JR. Hyperplastic polyposis. In Hamilton SR, Aaltonen LA, eds. Pathology and Genetics of Tumors of the Digestive System, Vol. 2. Lyon, France: IARC; 2000:135-136.
11. Rashid A, Houlihan PS, Booker S, Petersen GM, Giardiello FM, Hamilton SR. Phenotypic and molecular characteristics of hyperplastic polyposis. Gastroenterology. 2000;119:323-332.
12. Higuchi T, Jass JR. My approach to serrated polyps of the colorectum. J Clin Pathol. 2004;57:682-686.
13. Carvajal-Carmona LG, Howarth KM, Lockett M, et al. Molecular classification and genetic pathways in hyperplastic polyposis syndrome. J Pathol. 2007;212:378-385.
14. Lage P, Cravo M, Sousa R, et al. Management of Portuguese patients with hyperplastic polyposis and screening of at-risk first-degree relatives: a contribution for future guidelines based on a clinical study. Am J Gastroenterol. 2004;99:1779-1784.
15. Jass JR. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology. 2007;50:113-130.
16. O'Brien MJ, Yang S, Mack C, et al. Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points. Am J Surg Pathol. 2006;30:1491-1501.
17. Chan AO, Issa JP, Morris JS, Hamilton SR, Rashid A. Concordant CpG island methylation in hyperplastic polyposis. Am J Pathol. 2002;160:529-536. (Pubitemid 34160330)
18. Kambara T, Simms LA, Whitehall VL, et al. BRAF mutation is associated with DNA methylation inserrated polyps and cancers of the colorectum. Gut. 2004;53:1137-1144.
19. Minoo P, Baker K, Goswami R, et al. Extensive DNA methylation in normal colorectal mucosa in hyperplastic polyposis. Gut. 2006;55:1467-1474.
20. Wynter CV, Walsh MD, Higuchi T, Leggett BA, Yong J, Jass JR. Methylation patterns define two types of hyperplastic polyp associated with colorectal cancer. Gut. 2004;53:573-580.
21. Mishra DK, Chen Z, Wu Y, Sarkissyan M, Koeffler HP, Vadgama JV. Global methylation pattern of genes in androgen-sensitive and androgen-independent prostate cancer cells. Mol Cancer Ther. 2010;9:33-45.
22. Vanaja DK, Ehrich M, Van den Boom D, et al. Hypermethylation of genes for diagnosis and risk stratification of prostate cancer. Cancer Invest. 2009;27:549-560.
23. Sweet K, Willis J, Zhou XP, et al. Molecular classification of patients with unexplained hamartomatous and hyperplastic polyposis. JAMA. 2005;294:2465-2473.
24. Jarrar AM, Church JM, Fay S, Kalady MF. Is the phenotype mixed or mistaken? Hereditary nonpolyposis colorectal cancer and hyperplastic polyposis syndrome. Dis Colon Rectum. 2009;52:1949-1955.